We use cookies to better understand how you use our site and to improve your experience by personalizing content. Please review our updated Privacy Policy and Terms of Use. If you accept the use of cookies, please click the "I accept" button.I acceptI declineX
Skip navigational links

Life Sciences Newsletter, March 2008


Volume 2, Issue 1
Editor: Seth David Levy, Esquire

  • A Crippling Blow? CMS Price Reporting Rule May Chill Authorized Generics
    Anna Kraus, Esquire, and Stefanie Doebler, Esquire

  • FDA Amendments Act of 2007: Changes for the Future
    Gabrielle Goldstein, Esquire

  • Research or Marketing: How to Avoid Pitfalls When Conducting Postmarketing Trials
    Decanda Faulk, RN, Esquire, CHC, and Rachel Abramovitz, Esquire, LLB, LLM

  • Supreme Court Reviews Federal Preemption of State Claims for Damages in Medical Device Cases
    Stuart Silverman, Esquire

  • The EU Clinical Trials Directive and the Central/Eastern European Countries�Change for the Better, or Disincentive to Investment?
    Ned Milenkovich, Esquire, PharmD, and Monte Dube, Esquire

  • Staying Competitive In a Mobile Market: Steps to Protect Trade Secrets While Avoiding Claims of Misappropriation from Competitors
    Walter Stella, Esquire
© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105